1. Home
  2. Live Updates
  3. Aad

Live Breaking News & Updates on Aad

Stay informed with the latest breaking news from Aad on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Aad and stay connected to the pulse of your community

Dr Robert Sidbury on Implementing Value-Based Care Intiatives in a Pediatric Dermatology Practice

Robert Sidbury, MD, MPH, FAAD, division head of dermatology at Seattle Children's Hospital and professor of pediatrics at the University of Washington School of Medicine, discusses implementing value-based care initiatives in a pediatric dermatology practice.

United-states , American , Larry-eichenfield , Robert-sidbury , University-of-washington-school-medicine , American-academy-of-dermatology , American-journal , Managed-care , American-academy , Seattle-children , Washington-school , Dr-robert-sidbury

Dr Jonathan Silverberg Describes AD Diagnosis, Treatment in Children vs Adults

Jonathan Silverberg, MD, PhD, MPH, FAAD, of George Washington University School of Medicine and Health Sciences, discusses atopic dermatitis (AD) diagnosis and treatment differences in children vs adults.

United-states , American , Jonathan-silverberg , American-academy-of-dermatology , Health-sciences , George-washington-university-school-of-medicine , American-journal , Managed-care , American-academy , George-washington-university-school , Dr-jonathan-silverberg , Atopic-dermatitis

Dr Monica Li Lists Microneedling Considerations, Precautions

Monica Li, MD, medical and cosmetic dermatologist, listed microneedling considerations and precautions so that providers can safely implement the procedure.






United-states , United-kingdom , British , American , Monica-li , University-of-british-columbia , American-academy-of-dermatology , American-journal , American-academy , Dr-monica-li , Aad , Microneedling

Building a Psoriasis Knockout Regimen Around Risankizumab, with Andrew Blauvelt, MD, MBA

Blauvelt discusses the future research of higher-dose risankizumab for patients with psoriasis—and why it may be "disruptive in the treatment space."

Oregon , United-states , San-diego , California , American , Andrew-blauvelt , American-academy-of-dermatology , Oregon-medical-research-center , American-academy , Aad , Psoriasis , Knockout

Iltefat Hamzavi, MD: Long-Term Implications of New Data on Upadacitinib for Nonsegmental Vitiligo

In this segment of his AAD interview, Hamzavi discussed more about his team’s findings on upadacitinib as well as their implications and future in terms of research.

United-states , American , Iltefat-hamzavi , American-academy-of-dermatology , Henry-ford-health-system-department , Global-vitiligo-foundation , Henry-ford-health-system , Upadacitinib , Vitiligo , Nonsegmental , Aad ,

Jonathan Silverberg, MD, PhD: New Phase 3 Findings on Nemolizumab for Atopic Dermatitis

This interview at AAD featured a discussion with Silverberg on nemolizumab’s efficacy and safety at Week 48 among patients with moderate-to-severe atopic dermatitis.


United-states , Berlin , Germany , San-diego , California , American , Jonathan-silverberg , George-washington-university-school-of-medicine , European-academy-of-dermatology , American-academy-of-dermatology , Health-sciences , Annual-meeting

Discussing New Phase 2 Findings on Lutikizumab for Hidradenitis Suppurativa with Alexa Kimball, MD, MPH

Kimball discusses her team’s new late-breaking data regarding the safety and effectiveness of lutikizumab in treating the symptoms of moderate-to-severe HS in adult non-responders to anti-TNF therapy.


Massachusetts , United-states , American , Alexa-kimball , Harvard-medical-school , American-academy-of-dermatology , Annual-meeting , Hidradenitis-suppurativa-clinical-response , Massachusetts-general-hospital , Numeric-rating-scale , Global-assessment , Hs

Ruxolitinib Cream Is Tolerable and Effective in Cutaneous GVHD

A cream formulation of ruxolitinib was deemed safe and effective compared with placebo in patients with cutaneous graft-versus-host disease.

Alina-markova , Cellular-therapy-meetings , Inpatient-consultative-dermatology , Dermatology-service , Memorial-sloan-kettering-cancer-center , Global-assessment , Clinical-condition , Composite-assessment , Index-lesion-disease-severity , Dermtech-smart , Cream-formulation-of-ruxolitinib-

13 Best Caffeine Eye Creams, Reviewed by Dermatologists

For those mornings when you need an extra shot.Originally Appeared on Glamour

New-york , United-states , Marisa-garshick , Aya-ahram , Navins-arora , Grossman-school-of-medicine , Weill-cornell-medicine , Hudson-dermatology , Laser-surgery , Borealis-dermatology , Caffeine-eye-cream , Aad

American Academy of Dermatology Reveals New Acne Vulgaris Guidelines

In new guidelines by the AAD, 18 new evidence-based recommendations and 5 practice statements were described for patients 9 years of age and older with acne.

United-states , Americans , American , Johns-barbieri , Work-group , American-academy-of-dermatology , Evidinno-inc , American-academy , Guideline-workgroup , Working-group , Acne